Thalidomide for the Treatment of Myelodysplastic Syndrome in Taiwan: Results of a Phase II Trial
Anticancer Research, 07/27/2012
Clinical Article
Chung CY et al. – Low–dose thalidomide is an effective and safe treatment for patients with low–risk myelodysplastic syndrome (MDS).



